$0.3901
At close: Feb 18, 10:03 AM EDT
Comments
Loading...
Crescita Therapeutics Analyst Ratings and Price Targets | OTC:CRRTF | Benzinga
Crescita Therapeutics Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Crescita Therapeutics Corp from these most-recent analyst ratings.
Analyst Ratings for Crescita Therapeutics
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Crescita Therapeutics (CRRTF) stock?
There is no price target for Crescita Therapeutics
What is the most recent analyst rating for Crescita Therapeutics (CRRTF)?
There is no analyst for Crescita Therapeutics
When was the last upgrade for Crescita Therapeutics (CRRTF)?
There is no last upgrade for Crescita Therapeutics
When was the last downgrade for Crescita Therapeutics (CRRTF)?
There is no last downgrade for Crescita Therapeutics.
When is the next analyst rating going to be posted or updated for Crescita Therapeutics (CRRTF)?
There is no next analyst rating for Crescita Therapeutics.
Is the Analyst Rating Crescita Therapeutics (CRRTF) correct?
There is no next analyst rating for Crescita Therapeutics.
Browse analyst ratings and price targets on all stocks.
